{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T22:24:25Z","timestamp":1792794265268,"version":"4.5.0"},"reference-count":42,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,16]],"date-time":"2024-10-16T00:00:00Z","timestamp":1729036800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100031143","name":"GEn1E Lifesciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100031143","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01HL69057"],"award-info":[{"award-number":["R01HL69057"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000738","name":"U.S. Department of Veterans Affairs","doi-asserted-by":"publisher","award":["BX004270"],"award-info":[{"award-number":["BX004270"]}],"id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005902","name":"Institute for Clinical and Translational Research, University of Wisconsin, Madison","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005902","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007496","name":"Veterans Health Administration Biomedical Laboratory Research and Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007496","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1124\/jpet.124.002281","type":"journal-article","created":{"date-parts":[[2024,9,16]],"date-time":"2024-09-16T11:35:19Z","timestamp":1726486519000},"page":"100031","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["First-in-class mitogen-activated protein kinase (MAPK) p38\u03b1: MAPK-activated protein kinase 2 dual signal modulator with anti-inflammatory and endothelial-stabilizing properties"],"prefix":"10.1016","volume":"392","author":[{"given":"Mohan E.","family":"Tulapurkar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kari Ann","family":"Shirey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katerina","family":"Lugkey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wendy","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ritu","family":"Lal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Galan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omar","family":"Mahmoud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathaniel","family":"McClean","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiruphagaran","family":"Thangaraju","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Cericola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Lewis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7476-9248","authenticated-orcid":false,"given":"William A.","family":"Murphy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Fletcher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr","given":"Alexander D.","family":"MacKerell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefanie N.","family":"Vogel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Shapiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5011-5621","authenticated-orcid":false,"given":"Jeffrey D.","family":"Hasday","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/jpet.124.002281_bib1","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.softx.2015.06.001","article-title":"GROMACS: high performance molecular simulations through multi-level parallelism from laptops to supercomputers","volume":"1\u20132","author":"Abraham","year":"2015","journal-title":"SoftwareX"},{"key":"10.1124\/jpet.124.002281_bib42","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1021\/ci200387c","article-title":"Revisiting the general solubility equation: in silico prediction of aqueous solubility incorporating the effect of topographical polar surface area","volume":"52","author":"Ali","year":"2012","journal-title":"J Chem Inf Model"},{"key":"10.1124\/jpet.124.002281_bib2","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/S0960-9822(98)70442-7","article-title":"Nuclear export of the stress-activated protein kinase p38 mediated by its substrate MAPKAP kinase-2","volume":"8","author":"Ben-Levy","year":"1998","journal-title":"Curr Biol"},{"key":"10.1124\/jpet.124.002281_bib3","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1074\/jbc.M110.177899","article-title":"Quantitative analysis of ERK2 interactions with substrate proteins: roles for kinase docking domains and activity in determining binding affinity","volume":"286","author":"Burkhard","year":"2011","journal-title":"J\u00a0Biol Chem"},{"key":"10.1124\/jpet.124.002281_bib4","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1038\/s41580-020-00322-w","article-title":"Diversity and versatility of p38 kinase signalling in health and disease","volume":"22","author":"Canovas","year":"2021","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1124\/jpet.124.002281_bib5","doi-asserted-by":"crossref","first-page":"6281","DOI":"10.1016\/j.bmcl.2006.09.038","article-title":"Characterization of ATP-independent ERK inhibitors identified through in silico analysis of the active ERK2 structure","volume":"16","author":"Chen","year":"2006","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1124\/jpet.124.002281_bib6","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1161\/CIRCULATIONAHA.110.971986","article-title":"Inhibition of p38 mitogen-activated protein kinase improves nitric oxide-mediated vasodilatation and reduces inflammation in hypercholesterolemia","volume":"123","author":"Cheriyan","year":"2011","journal-title":"Circulation"},{"key":"10.1124\/jpet.124.002281_bib7","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1002\/art.24485","article-title":"Efficacy, pharmacodynamics, and safety of VX-702, a novel p38 MAPK inhibitor, in rheumatoid arthritis: results of two randomized, double-blind, placebo-controlled clinical studies","volume":"60","author":"Damjanov","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1124\/jpet.124.002281_bib8","doi-asserted-by":"crossref","first-page":"12624","DOI":"10.1074\/jbc.RA119.007525","article-title":"A\u00a0temperature-dependent conformational shift in p38\u03b1 MAP kinase substrate binding region associated with changes in substrate phosphorylation profile","volume":"294","author":"Deredge","year":"2019","journal-title":"J\u00a0Biol Chem"},{"key":"10.1124\/jpet.124.002281_bib9","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1515\/hsz-2013-0197","article-title":"What goes up must come down: molecular basis of MAPKAP kinase 2\/3-dependent regulation of the inflammatory response and its inhibition","volume":"394","author":"Gaestel","year":"2013","journal-title":"Biol Chem"},{"key":"10.1124\/jpet.124.002281_bib10","doi-asserted-by":"crossref","first-page":"8844","DOI":"10.1039\/D1SC01781K","article-title":"Rapid and accurate estimation of protein-ligand relative binding affinities using site-identification by ligand competitive saturation","volume":"12","author":"Goel","year":"2021","journal-title":"Chem Sci"},{"key":"10.1124\/jpet.124.002281_bib11","first-page":"123","article-title":"Safety, tolerability, pharmacokinetics, and pharmacodynamics of the MK2 inhibitor ATI-450 in healthy subjects: a placebo-controlled, randomized phase 1 study","volume":"13","author":"Gordon","year":"2021","journal-title":"Clin Pharmacol"},{"key":"10.1124\/jpet.124.002281_bib12","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1002\/acr2.11517","article-title":"Selective inhibition of the MK2 pathway: data from a phase IIa randomized clinical trial in rheumatoid arthritis","volume":"5","author":"Gordon","year":"2023","journal-title":"ACR Open Rheumatol"},{"key":"10.1124\/jpet.124.002281_bib13","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1000435","article-title":"Computational fragment-based binding site identification by ligand competitive saturation","volume":"5","author":"Guvench","year":"2009","journal-title":"PLoS Comput Biol"},{"key":"10.1124\/jpet.124.002281_bib14","doi-asserted-by":"crossref","first-page":"4586","DOI":"10.1021\/jm0501174","article-title":"Identification of novel extracellular signal-regulated kinase docking domain inhibitors","volume":"48","author":"Hancock","year":"2005","journal-title":"J\u00a0Med Chem"},{"key":"10.1124\/jpet.124.002281_bib15","doi-asserted-by":"crossref","first-page":"213","DOI":"10.2174\/157340606776056151","article-title":"Mitogen activated protein (MAP) kinases: development of ATP and non-ATP dependent inhibitors","volume":"2","author":"Hancock","year":"2006","journal-title":"Med Chem"},{"key":"10.1124\/jpet.124.002281_bib16","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/nmeth.4067","article-title":"CHARMM36m: an improved force field for folded and intrinsically disordered proteins","volume":"14","author":"Huang","year":"2017","journal-title":"Nat Methods"},{"key":"10.1124\/jpet.124.002281_bib17","first-page":"926","article-title":"Comparison of simple potential functions for simulating liquid water","volume":"79","author":"Jorgensen","year":"1983","journal-title":"J\u00a0Chem Phys"},{"key":"10.1124\/jpet.124.002281_bib18","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1038\/ni.1640","article-title":"The kinase p38 alpha serves cell type-specific inflammatory functions in skin injury and coordinates pro- and anti-inflammatory gene expression","volume":"9","author":"Kim","year":"2008","journal-title":"Nat Immunol"},{"key":"10.1124\/jpet.124.002281_bib19","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.1021\/ct500201y","article-title":"Sampling of organic solutes in aqueous and heterogeneous environments using oscillating excess grand canonical-like Monte Carlo-molecular dynamics simulations","volume":"10","author":"Lakkaraju","year":"2014","journal-title":"J\u00a0Chem Theory Comput"},{"key":"10.1124\/jpet.124.002281_bib20","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1021\/ci500729k","article-title":"Mapping functional group free energy patterns at protein occluded sites: nuclear receptors and G-protein coupled receptors","volume":"55","author":"Lakkaraju","year":"2015","journal-title":"J\u00a0Chem Inf Model"},{"key":"10.1124\/jpet.124.002281_bib21","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1136\/thoraxjnl-2012-202744","article-title":"Efficacy and safety of the oral p38 inhibitor PH-797804 in chronic obstructive pulmonary disease: a randomised clinical trial","volume":"68","author":"MacNee","year":"2013","journal-title":"Thorax"},{"key":"10.1124\/jpet.124.002281_bib22","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.trsl.2022.06.005","article-title":"Discovery of CC-99677, a selective targeted covalent MAPKAPK2 (MK2) inhibitor for autoimmune disorders","volume":"249","author":"Malona","year":"2022","journal-title":"Transl Res"},{"key":"10.1124\/jpet.124.002281_bib23","doi-asserted-by":"crossref","first-page":"e123","DOI":"10.1016\/j.ddmec.2010.07.006","article-title":"Developing small molecules to inhibit kinases unkind to the heart: p38 MAPK as a case in point","volume":"7","author":"Marber","year":"2010","journal-title":"Drug Discov Today Dis Mech"},{"key":"10.1124\/jpet.124.002281_bib24","doi-asserted-by":"crossref","first-page":"37401","DOI":"10.1074\/jbc.C200418200","article-title":"Structure of mitogen-activated protein kinase-activated protein (MAPKAP) kinase 2 suggests a bifunctional switch that couples kinase activation with nuclear export","volume":"277","author":"Meng","year":"2002","journal-title":"J\u00a0Biol Chem"},{"key":"10.1124\/jpet.124.002281_bib25","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.cels.2018.07.001","article-title":"Coral: clear and customizable visualization of human kinome data","volume":"7","author":"Metz","year":"2018","journal-title":"Cell Syst"},{"key":"10.1124\/jpet.124.002281_bib26","doi-asserted-by":"crossref","first-page":"332","DOI":"10.2174\/1389203716666150629121324","article-title":"Pivotal role of mitogen-activated protein kinase-activated protein kinase 2 in inflammatory pulmonary diseases","volume":"17","author":"Qian","year":"2016","journal-title":"Curr Protein Pept Sci"},{"key":"10.1124\/jpet.124.002281_bib27","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1161\/01.ATV.16.3.488","article-title":"Thrombin-induced increase in endothelial permeability is associated with changes in cell-to-cell junction organization","volume":"16","author":"Rabiet","year":"1996","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1124\/jpet.124.002281_bib28","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1021\/ci100462t","article-title":"Reproducing crystal binding modes of ligand functional groups using site-identification by ligand competitive saturation (SILCS) simulations","volume":"51","author":"Raman","year":"2011","journal-title":"J\u00a0Chem Inf Model"},{"key":"10.1124\/jpet.124.002281_bib29","doi-asserted-by":"crossref","first-page":"3384","DOI":"10.1021\/ci4005628","article-title":"Inclusion of multiple fragment types in the site identification by ligand competitive saturation (SILCS) approach","volume":"53","author":"Raman","year":"2013","journal-title":"J\u00a0Chem Inf Model"},{"key":"10.1124\/jpet.124.002281_bib30","doi-asserted-by":"crossref","first-page":"3676","DOI":"10.4049\/jimmunol.174.6.3676","article-title":"Febrile-range hyperthermia augments neutrophil accumulation and enhances lung injury in experimental gram-negative bacterial pneumonia","volume":"174","author":"Rice","year":"2005","journal-title":"J\u00a0Immunol"},{"key":"10.1124\/jpet.124.002281_bib31","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20200675","article-title":"A\u00a0mouse model of human TLR4 D299G\/T399I SNPs reveals mechanisms of altered LPS and pathogen responses","volume":"218","author":"Richard","year":"2021","journal-title":"J\u00a0Exp Med"},{"key":"10.1124\/jpet.124.002281_bib32","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.cgh.2005.11.013","article-title":"Oral p38 mitogen-activated protein kinase inhibition with BIRB 796 for active Crohn\u2019s disease: a randomized, double-blind, placebo-controlled trial","volume":"4","author":"Schreiber","year":"2006","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1124\/jpet.124.002281_bib33","first-page":"3926","article-title":"Novel non-catalytic substrate-selective p38\u03b1-specific MAPK inhibitors with endothelial-stabilizing and anti-inflammatory activity","volume":"15","author":"Shah","year":"2017","journal-title":"J\u00a0Immunol"},{"key":"10.1124\/jpet.124.002281_bib34","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1038\/nature12118","article-title":"The TLR4 antagonist Eritoran protects mice from lethal influenza infection","volume":"497","author":"Shirey","year":"2013","journal-title":"Nature"},{"key":"10.1124\/jpet.124.002281_bib35","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1177\/0960327117715901","article-title":"Differential effect of p38 and MK2 kinase inhibitors on the inflammatory and toxicity biomarkers in\u00a0vitro","volume":"37","author":"Singh","year":"2018","journal-title":"Hum Exp Toxicol"},{"key":"10.1124\/jpet.124.002281_bib36","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1093\/emboj\/20.3.466","article-title":"Identification of a docking groove on ERK and p38 MAP kinases that regulates the specificity of docking interactions","volume":"20","author":"Tanoue","year":"2001","journal-title":"EMBO J"},{"key":"10.1124\/jpet.124.002281_bib37","doi-asserted-by":"crossref","first-page":"3018","DOI":"10.1021\/acs.jcim.9b00210","article-title":"Optimization and evaluation of site-identification by ligand competitive saturation (SILCS) as a tool for target-based ligand optimization","volume":"59","author":"Ustach","year":"2019","journal-title":"J\u00a0Chem Inf Model"},{"key":"10.1124\/jpet.124.002281_bib38","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1002\/jcc.21367","article-title":"CHARMM general force field: a force field for drug-like molecules compatible with the CHARMM all-atom additive biological force fields","volume":"31","author":"Vanommeslaeghe","year":"2010","journal-title":"J\u00a0Comput Chem"},{"key":"10.1124\/jpet.124.002281_bib39","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1084\/jem.20172063","article-title":"Selective inhibition of the p38alpha MAPK-MK2 axis inhibits inflammatory cues including inflammasome priming signals","volume":"215","author":"Wang","year":"2018","journal-title":"J\u00a0Exp Med"},{"key":"10.1124\/jpet.124.002281_bib40","doi-asserted-by":"crossref","first-page":"30687","DOI":"10.1073\/pnas.2012939117","article-title":"The SKI complex is a broad-spectrum, host-directed antiviral drug target for coronaviruses, influenza, and filoviruses","volume":"117","author":"Weston","year":"2020","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1124\/jpet.124.002281_bib41","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1080\/13543776.2023.2242584","article-title":"A\u00a0patent review of MAPK inhibitors (2018-present)","volume":"33","author":"Wydra","year":"2023","journal-title":"Expert Opin Ther Pat"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524000892?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524000892?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/jpet.124.002281","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T22:30:45Z","timestamp":1762209045000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356524000892"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":42,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["S0022356524000892"],"URL":"https:\/\/doi.org\/10.1124\/jpet.124.002281","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"First-in-class mitogen-activated protein kinase (MAPK) p38\u03b1: MAPK-activated protein kinase 2 dual signal modulator with anti-inflammatory and endothelial-stabilizing properties","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/jpet.124.002281","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.jpet.2024.100039","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Inc. on behalf of American Society for Pharmacology and Experimental Therapeutics.","name":"copyright","label":"Copyright"}],"article-number":"100031"}}